{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:40:28Z","timestamp":1761183628064,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jphs.2021.05.010","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T07:00:41Z","timestamp":1623481241000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients"],"prefix":"10.1016","volume":"147","author":[{"given":"Yuki","family":"Kawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Toya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Azushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Kinguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jphs.2021.05.010_bib1","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1681\/ASN.V8121921","article-title":"Anemia in hemodialysis patients: variables affecting this outcome predictor","volume":"8","author":"Madore","year":"1997","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jphs.2021.05.010_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1523-1755.2004.00584.x","article-title":"Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States","volume":"65","author":"Li","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jphs.2021.05.010_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.ajkd.2004.03.023","article-title":"Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Pisoni","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jphs.2021.05.010_bib4","first-page":"ii1","article-title":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.010_bib5","first-page":"279","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.jphs.2021.05.010_bib6","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney Disease: improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jphs.2021.05.010_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41100-017-0114-y","article-title":"2015 Japanese Society for dialysis therapy: guidelines for renal anemia in chronic kidney disease","volume":"3","author":"Yamamoto","year":"2017","journal-title":"Renal Replace Ther"},{"issue":"11","key":"10.1016\/j.jphs.2021.05.010_bib8","first-page":"2070","article-title":"Importance of iron supply for erythropoietin therapy","volume":"10","author":"Sunder-Plassmann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.jphs.2021.05.010_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/CNP57136","article-title":"Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients","volume":"57","author":"Chang","year":"2002","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.010_bib10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9539","key":"10.1016\/j.jphs.2021.05.010_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(06)69120-4","article-title":"Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia","volume":"368","author":"Macdougall","year":"2006","journal-title":"Lancet"},{"issue":"9596","key":"10.1016\/j.jphs.2021.05.010_bib12","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(07)61599-2","article-title":"Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)","volume":"370","author":"Levin","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.010_bib13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2215\/CJN.03631006","article-title":"Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly","volume":"2","author":"Sulowicz","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.jphs.2021.05.010_bib14","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","article-title":"A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload","volume":"276","author":"Pigeon","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"5704","key":"10.1016\/j.jphs.2021.05.010_bib15","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.jphs.2021.05.010_bib16","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"Ganz","year":"2011","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jphs.2021.05.010_bib17","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2015-12-639112","article-title":"Hepcidin in the diagnosis of iron disorders","volume":"127","author":"Girelli","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.010_bib18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.jphs.2021.05.010_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/1744-9987.12248","article-title":"Twice-monthly administration of a lower dose of epoetin beta pegol can maintain adequate hemoglobin levels in hemodialysis patients","volume":"19","author":"Morikami","year":"2015","journal-title":"Ther Apher Dial"},{"issue":"3\u20134","key":"10.1016\/j.jphs.2021.05.010_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000368391","article-title":"A randomized control study on the procedure for switching epoetin beta (EPO) to epoetin beta pegol (CERA) in the treatment of renal anemia in maintenance hemodialysis patients","volume":"38","author":"Toida","year":"2014","journal-title":"Blood Purif"},{"issue":"5","key":"10.1016\/j.jphs.2021.05.010_bib21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/1744-9987.12164","article-title":"Comparison of 2-week versus 4-week dosing intervals of epoetin beta pegol on erythropoiesis and iron metabolism in hemodialysis patients","volume":"18","author":"Morikami","year":"2014","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.010_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","article-title":"Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation","volume":"102","author":"Ganz","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jphs.2021.05.010_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/1744-9987.12161","article-title":"Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study","volume":"18","author":"Kakimoto-Shino","year":"2014","journal-title":"Ther Apher Dial"},{"issue":"4","key":"10.1016\/j.jphs.2021.05.010_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/jch.14171","article-title":"Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: a randomized controlled trial","volume":"23","author":"Kawai","year":"2021","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"6","key":"10.1016\/j.jphs.2021.05.010_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10157-012-0694-3","article-title":"Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?","volume":"16","author":"Nakanishi","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"10.1016\/j.jphs.2021.05.010_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/1744-9987.12322","article-title":"Effects of long-term erythropoiesis-stimulating agents on iron metabolism in patients on hemodialysis","volume":"19","author":"Onuma","year":"2015","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1016\/j.jphs.2021.05.010_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000362212","article-title":"Regulation of Hepcidin-25 by short- and long-acting rhEPO may be dependent on Ferritin and predict the response to rhEPO in hemodialysis patients","volume":"4","author":"Takasawa","year":"2014","journal-title":"Nephron Extra"},{"issue":"11","key":"10.1016\/j.jphs.2021.05.010_bib28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1515\/CCLM.2005.207","article-title":"Reticulocyte hemoglobin measurement-comparison of two methods in the diagnosis of iron-restricted erythropoiesis","volume":"43","author":"Thomas","year":"2005","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.jphs.2021.05.010_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.1997.323","article-title":"Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients","volume":"52","author":"Fishbane","year":"1997","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jphs.2021.05.010_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V96.3.823","article-title":"Erythropoietin, iron, and erythropoiesis","volume":"96","author":"Goodnough","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jphs.2021.05.010_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/1744-9987.12237","article-title":"Acceleration of iron utilization after intravenous iron administration during activated erythropoiesis in hemodialysis patients: a randomized study","volume":"19","author":"Kuji","year":"2015","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1016\/j.jphs.2021.05.010_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s101570300007","article-title":"Assessment of iron deficiency in chronic hemodialysis patients: investigation of cutoff values for reticulocyte hemoglobin content","volume":"7","author":"Mitsuiki","year":"2003","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"10.1016\/j.jphs.2021.05.010_bib33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1515\/CCLM.2010.292","article-title":"Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis","volume":"48","author":"Piva","year":"2010","journal-title":"Clin Chem Lab Med"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:02:02Z","timestamp":1761163322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861321000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1347861321000529"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2021.05.010","relation":{},"ISSN":["1347-8613"],"issn-type":[{"type":"print","value":"1347-8613"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2021.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}